BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 1,827 shares, a decrease of 56.9% from the April 15th total of 4,242 shares. Based on an average daily volume of 2,431 shares, the short-interest ratio is currently 0.8 days.
BioSyent Stock Performance
OTCMKTS BIOYF opened at $10.58 on Friday. BioSyent has a 52 week low of $7.63 and a 52 week high of $12.00. The company has a 50-day moving average price of $10.87 and a two-hundred day moving average price of $9.75.
BioSyent Company Profile
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Read More
- Five stocks we like better than BioSyent
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
- YETI Rallies After Earnings Beat and Raised Outlook
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
